University Medical Centre Ljubljana: Heart Failure trials

The registry lists 10 Heart Failure studies with University Medical Centre Ljubljana as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 6No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo SyndromeRecruitingNCT07604467
• Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer PatientsRecruitingNCT07245069Phase 2
• Mechanisms of Semaglutide Therapy in Heart Failure PatientsRecruitingNCT06541509Phase 1/2
• Cardiovascular Genistein Therapy for Heart Failure InflammationRecruitingNCT06501768Phase 1/2
• Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device SupportRecruitingNCT06154044Phase 2
• Effects of SGLT2 Inhibitors on Erythropoiesis in Heart FailureActive, not recruitingNCT07478575
• Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node AblationActive, not recruitingNCT05467163Not applicable
• Cell Therapy in HFpEFCompletedNCT02923609Phase 2
• Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated CardiomyopathyCompletedNCT01350310Phase 2
• Skeletal Muscle Oxygenation in Critically IllStatus unknownNCT00384644